Free Trial
NYSE:NNVC

NanoViricides (NNVC) Stock Price, News & Analysis

NanoViricides logo
$1.39 -0.03 (-1.77%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$1.41 +0.02 (+1.44%)
As of 08/29/2025 06:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About NanoViricides Stock (NYSE:NNVC)

Key Stats

Today's Range
$1.37
$1.42
50-Day Range
$1.23
$1.75
52-Week Range
$0.94
$2.02
Volume
109,378 shs
Average Volume
238,649 shs
Market Capitalization
$22.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NanoViricides Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
8th Percentile Overall Score

NNVC MarketRank™: 

NanoViricides scored higher than 8% of companies evaluated by MarketBeat, and ranked 920th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for NanoViricides.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NanoViricides is -1.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NanoViricides is -1.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    NanoViricides has a P/B Ratio of 2.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.57% of the float of NanoViricides has been sold short.
  • Short Interest Ratio / Days to Cover

    NanoViricides has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NanoViricides has recently decreased by 19.91%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    NanoViricides does not currently pay a dividend.

  • Dividend Growth

    NanoViricides does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.57% of the float of NanoViricides has been sold short.
  • Short Interest Ratio / Days to Cover

    NanoViricides has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NanoViricides has recently decreased by 19.91%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    NanoViricides has a news sentiment score of -0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.05 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for NanoViricides this week, compared to 1 article on an average week.
  • Search Interest

    Only 3 people have searched for NNVC on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • MarketBeat Follows

    14 people have added NanoViricides to their MarketBeat watchlist in the last 30 days. This is an increase of 367% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, NanoViricides insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.60% of the stock of NanoViricides is held by insiders.

  • Percentage Held by Institutions

    Only 10.30% of the stock of NanoViricides is held by institutions.

  • Read more about NanoViricides' insider trading history.
Receive NNVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NNVC Stock News Headlines

Buffett to put 90% of his money in this one stock?
CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who’s also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman’s own mom earn 3,400%.tc pixel
See More Headlines

NNVC Stock Analysis - Frequently Asked Questions

NanoViricides' stock was trading at $1.43 on January 1st, 2025. Since then, NNVC stock has decreased by 2.8% and is now trading at $1.39.

NanoViricides, Inc. (NYSE:NNVC) issued its earnings results on Friday, September, 27th. The company reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.01.

NanoViricides shares reverse split on the morning of Tuesday, September 24th 2019.The 1-20 reverse split was announced on Thursday, September 12th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 23rd 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

NanoViricides' top institutional investors include XTX Topco Ltd (0.13%).
View institutional ownership trends
.

Shares of NNVC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NanoViricides investors own include Cytosorbents (CTSO), Rekor Systems (REKR), NVIDIA (NVDA), Micron Technology (MU), Inovio Pharmaceuticals (INO), Meta Platforms (META) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
9/27/2024
Today
8/30/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:NNVC
CIK
1379006
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.29 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-87.90%
Return on Assets
-78.69%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.44
Quick Ratio
2.47

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.66 per share
Price / Book
2.11

Miscellaneous

Outstanding Shares
16,072,000
Free Float
14,922,000
Market Cap
$22.34 million
Optionable
Optionable
Beta
0.96

Social Links

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSE:NNVC) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners